(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
1.14% KRW 26 650
Live Chart Being Loaded With Signals
Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu...
Stats | |
---|---|
Volumen de hoy | 283.00 |
Volumen promedio | 397.00 |
Capitalización de mercado | 714.45B |
EPS | KRW0 ( 2023-09-30 ) |
Próxima fecha de ganancias | ( KRW0 ) 2024-05-13 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW89.29 (0.34%) |
Green Cross Holdings Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Green Cross Holdings Finanzas
Annual | 2023 |
Ingresos: | KRW2 057.94B |
Beneficio Bruto: | KRW563.69B (27.39 %) |
EPS: | KRW-1 192.38 |
FY | 2023 |
Ingresos: | KRW2 057.94B |
Beneficio Bruto: | KRW563.69B (27.39 %) |
EPS: | KRW-1 192.38 |
FY | 2022 |
Ingresos: | KRW2 079.56B |
Beneficio Bruto: | KRW698.34B (33.58 %) |
EPS: | KRW1 297.25 |
FY | 2021 |
Ingresos: | KRW1 840.56B |
Beneficio Bruto: | KRW628.54B (34.15 %) |
EPS: | KRW1 222.00 |
Financial Reports:
No articles found.
Green Cross Holdings
Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico